When will Alcon report earnings and why does it matter for ALC.SW stock

Alcon reports on **24 Feb 2026**. The print matters because management will update margins, surgical volumes, and Vision Care rollout. Those items directly affect short-term revenue and the outlook for ALC.SW stock

What valuation metrics should investors watch for ALC.SW stock

Watch **PE 39.46**, **EPS 1.62**, and **free cash flow yield 3.92%**. Also track book value per share **CHF 44.74** and operating margins to assess whether ALC.SW stock justifies its premium valuation

How does the TOTAL30 launch affect the ALC.SW stock outlook

TOTAL30 Multifocal for Astigmatism expands Alcon’s premium contact lens range. Successful adoption could raise recurring revenue and retention, supporting the ALC.SW stock outlook if fitting rates and repeat orders scale

What is Meyka AI’s short-term forecast for ALC.SW stock

Meyka AI's forecast model projects **CHF 61.27** for the year, implying **-4.17%** versus today. Forecasts are model-based projections and not guarantees

CH Stocks

Alcon Inc. (ALC.SW, SIX) earnings 24 Feb 2026: watch margins and guidance

ByDanny Kontos February 20, 2026February 20, 2026

ALC.SW stock faces a crucial earnings report after Alcon Inc. set results for 24 Feb 2026. We expect margins and U.S. Vision Care growth to drive the print. Alcon trades on the SIX in Switzerland at CHF 63.92 with a PE of 39.46 and EPS of 1.62. Ahead of the report, investors should watch revenue mix, surgical procedure volumes, and adoption of new contact lenses as near-term drivers.